Academic junior doctor at Bristol Medical School. BMBS from Brighton and Sussex Medical School (2016) and an MSc in Control of Infectious Diseases from London School of Hygiene and Tropical Medicine. Research interests include qualitative and public health/epidemiology research into HIV and Hepatitis C infection among high risk groups.

Jake is a Research Fellow with the Centre for Social Research in Health, UNSW Sydney, with a longstanding interest in the potential of qualitative research to challenge the stigmatised identities and discredited knowledges widely associated with people who inject drugs and/or are living with hepatitis C.

Evan completed his PhD in 2017 looking at the transmission and treatment of hepatitis C infection among people who inject drugs. He now works as a postdoctoral fellow at the Kirby Institute at the University of New South Wales in Sydney, Australia.

Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent's Hospital, Sydney.

Håvard Midgard is a MD in gastroenterology/hepatology at Oslo University Hospital. He holds a PhD on HCV infection among PWID. His research has focused on HCV reinfection, treatment uptake and low-threshold models of care. He is a board member of INHSU and co-chaired the 2016 INHSU Symposium in Oslo.